InvestorsHub Logo
icon url

Gogo1121

01/20/11 10:31 AM

#248 RE: rickochey #247

The management on this company is astonished by the current valuation. In their interpretation of the recent news shares of BVTI should be trading north of $2 a shares. The damage associated with the sale of shares by creditors wasn't anticipated but, as most biotech companies know they have little to do with the streets interpretation of value. As news unfolds over the next few months shares should respond positively.